Iotrolan

Drug #1158

Iotrolan is used for diagnostic procedures such as myelography, lymphography, arthrography etc.

Primary Characteristics

It belongs to Isophthalamide.

It is classified in Non Ionic Contrast Medium pharmacological group.

Molecular Weight: 1626.2 · Solubility in Water: very soluble · Solubility in Alcohol: Insoluble · Non-proprietary name: Iotrolan.

Pharmacokinetics

Elimination: renal excretion is 80 %.

Indications

Iotrolan is primarily indicated in conditions like Arthrography, Liver transplant, Myelography, Non ionic contrast medium.

Iotrolan is also indicated for secondary conditions like Computed tomography scans.

Contraindications

Iotrolan is contraindicated in conditions like Hyperthyroidism, Inflammation.

Dosage

Iotrolan's dosage details are as follows:

Dose	Single Dose	Frequency
Adult Dosage
57.7 %	57.7 %	—
Paediatric Dosage (20kg)
No data.
Neonatal Dosage (3kg)
No data.

Drug Interactions

None recorded.

Side Effects

Iotrolan in overdosage may give rise to further complications which include Meningitis .

Iotrolan is known to cause more or less tolerable side effects which are usually transient. These include Fever, Headache, Nausea, Neck stiffiness, Vomiting .

Warnings / Precautions

Iotrolan should be administered with great caution in patients with asthma and history of allergy, and should be avoided to patients with known hypersensitivity to iodine or contrast media. Caution is needed in patients with severe hepatic (liver) or renal impairment or who may be at a risk of renal failure. Dehydration patients should have their fluid and electrolyte balance corrected before administration of contrast medium. It should be used with extreme caution in patients with hypertension, cardiac disease, phaeochromocytoma, sickle-cell anemia or hypothyroidism. Avoid use during pregnancy.

Available Brands

None recorded.

Storage Conditions

Iotrolan should be stored .

Drug Classification

1.14.2 — Radiocontrast media